# The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia

> **NCT04076371** · NA · COMPLETED · sponsor: **Beijing HuiLongGuan Hospital** · enrollment: 1640 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** olanzapine-sertraline combination
- **DRUG:** only olanzapine
- **DRUG:** risperidone-sertraline combination
- **DRUG:** only risperidone
- **DRUG:** paliperidone-sertraline combination
- **DRUG:** only paliperidone
- **DRUG:** ziprasidone-sertraline combination
- **DRUG:** only ziprasidone

## Key facts

- **NCT ID:** NCT04076371
- **Lead sponsor:** Beijing HuiLongGuan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 1640 (ACTUAL)
- **Last updated:** 2019-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04076371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04076371, "The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04076371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*